Rating sputum cell quality in clinical trials for asthma and COPD treatment
Frauke Pedersen,1,2 Ulrich M Zissler,3 Henrik Watz,2 Klaus F Rabe,1 Jens M Hohlfeld,4,5 Olaf Holz41LungenClinic Grosshansdorf, Airway Research Center North (ARCN), German Center for Lung Research (DZL), Grosshansdorf, Germany; 2Pulmonary Research Institute at LungenClinic Grosshansdorf, Airway Resea...
Main Authors: | Pedersen F, Zissler UM, Watz H, Rabe KF, Hohlfeld JM, Holz O |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-01-01
|
Series: | International Journal of COPD |
Subjects: | |
Online Access: | https://www.dovepress.com/rating-sputum-cell-quality-in-clinical-trials-for-asthma-and-copd-trea-peer-reviewed-article-COPD |
Similar Items
-
Influence of Cell Quality on Inflammatory Biomarkers in COPD Sputum Supernatant
by: Pedersen F, et al.
Published: (2021-03-01) -
Induced sputum in the management of COPD: clinical implications
by: A. Zanini, et al.
Published: (2015-12-01) -
Markers of airway inflammation in pulmonary diseases assessed by induced sputum
by: S. Dragonieri, et al.
Published: (2016-01-01) -
Exploration of the sputum methylome and omics deconvolution by quadratic programming in molecular profiling of asthma and COPD: the road to sputum omics 2.0
by: Espen E. Groth, et al.
Published: (2020-10-01) -
Bacterial load and inflammatory response in sputum of alpha-1 antitrypsin deficiency patients with COPD
by: Balbi B, et al.
Published: (2019-08-01)